Stay updated on Dauno/Cytarabine ± Uproleselan in AML Clinical Trial

Sign up to get notified when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer now identifies the platform as revision v3.8.0 instead of v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-31T12:38:07.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH notice says agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.1%
    Check dated 2026-10-24T13:24:24.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov release as v3.7.2 instead of v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-17T14:27:12.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.0 to v3.7.1, with no change to the study record.
    Difference
    0.0%
    Check dated 2026-10-10T14:27:55.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Record history now includes a new revision entry v3.7.0. The prior revision v3.6.6 has been removed from the visible history.
    Difference
    0.0%
    Check dated 2026-09-19T20:17:14.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.6, was added to the record history and the older revision v3.6.5 was removed, indicating an update to the study record.
    Difference
    0.0%
    Check dated 2026-08-29T18:48:28.000Z thumbnail image

Stay in the know with updates to Dauno/Cytarabine ± Uproleselan in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.